Chemours (CC) PT Lowered to $19 at UBS
UBS analyst John Roberts lowered the price target on Chemours (NYSE: CC) to $19.00 (from $21.00) while maintaining a Neutral rating.
UBS analyst John Roberts lowered the price target on Chemours (NYSE: CC) to $19.00 (from $21.00) while maintaining a Neutral rating.